rs3735260

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -16 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_StrongBP6_Strong

The NM_015570.4(AUTS2):c.-3A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.0846 (AC=109,796) in the gnomAD database across 1,297,190 control chromosomes, including 5,804 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.258. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1768 hom., cov: 32)
Exomes 𝑓: 0.079 ( 4036 hom. )

Consequence

AUTS2
NM_015570.4 5_prime_UTR

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.04

Publications

10 publications found
Variant links:
Genes affected
AUTS2 (HGNC:14262): (activator of transcription and developmental regulator AUTS2) This gene has been implicated in neurodevelopment and as a candidate gene for numerous neurological disorders, including autism spectrum disorders, intellectual disability, and developmental delay. Mutations in this gene have also been associated with non-neurological disorders, such as acute lymphoblastic leukemia, aging of the skin, early-onset androgenetic alopecia, and certain cancers. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2014]
AUTS2 Gene-Disease associations (from GenCC):
  • autism spectrum disorder due to AUTS2 deficiency
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_015570.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -16 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BP6Reputable source reports benign
ClinVar 2-star benign — strong (BP6); ClinVar germline classification: Benign/Likely Benign, 2 star(s).
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.2577 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_015570.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

AUTS2 NM_015570.4
MANE Select
HGVSc / HGVSpc.-3A>G
Exon rankExon 1 of 19
5_prime_UTR
Prot: NP_056385.1UniProt: Q8WXX7-1
AUTS2 NM_001127231.3
HGVSc / HGVSpc.-3A>G
Exon rankExon 1 of 18
5_prime_UTR
Prot: NP_001120703.1UniProt: Q8WXX7-2
AUTS2 NM_001127232.3
HGVSc / HGVSpc.-3A>G
Exon rankExon 1 of 5
5_prime_UTR
Prot: NP_001120704.1UniProt: Q8WXX7-3

Ensembl Transcripts

AUTS2 ENST00000342771.10
TSL:1MANE Select
HGVSc / HGVSpc.-3A>G
Exon rankExon 1 of 19
5_prime_UTR
Prot: ENSP00000344087.4UniProt: Q8WXX7-1
AUTS2 ENST00000406775.6
TSL:1
HGVSc / HGVSpc.-3A>G
Exon rankExon 1 of 18
5_prime_UTR
Prot: ENSP00000385263.2UniProt: Q8WXX7-2
AUTS2 ENST00000403018.3
TSL:1
HGVSc / HGVSpc.-3A>G
Exon rankExon 1 of 5
5_prime_UTR
Prot: ENSP00000385572.2UniProt: Q8WXX7-3

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.126
AC:19102
Hom:1760
AN:151634
Cov:32
GnomAD2 exomes
AF: 0.0568
AC:497
AN:8750
GnomAD4 exome
AF: 0.0791
AC:90660
Hom:4036
AN:1145448
Cov:32
GnomAD4 genome
AF: 0.126
AC:19136
Hom:1768
AN:151742
Cov:32
TOPMed (Bravo)
AF: 0.134
AC:35340
Hom:3378
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.0939
AC:16784
Hom:1016
AN:178814
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.119
AC:279
Hom:24
AN:2342
ChinaMAP Phase 1
AF: 0.0917
Denmark Genome
AF: 0.0600
AC:18
AN:300
GenomeAsia100K
AF: 0.101
AC:351
AN:3476
Korea4K (4,157 Koreans)
AF: 0.0710
AC:515
AN:7210
Qatari Genome
AF: 0.182
AC:32
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.0507
AC:5762
Hom:132
AN:113658
Turkish Variome
AF: 0.0784
AC:121
Hom:6
AN:1544
UK10K
AF: 0.0726
AC:549
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.0782
AC:701
Hom:32
AN:8960
Showing 16 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.146 907462044 0.152 1355689076
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational Scores

AlphaGenome AVI
Uncertain16
BayesDel_noAF
Benign-0.59
CADD
Benign19
DANN
Benign0.83
GPN-Star LLR
N/A7.7
GPN-Star score
N/A3.3
Mutation Taster
N/A300/0polymorphism (auto)
PhyloP100
Benign1.0
PromoterAI
N/A0.043Neutral
Showing 9 of 9 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.